Personalised medicine

Photo

News • Swedish national initiative

Precision omics to boost data-driven medicine

The new national Precision Omics Initiative Sweden (PROMISE) aims to generate and integrate extensive molecular data to create a model for precision medicine implementation for Sweden.

Photo

Article • Spanish registry offers unprecedented data

ROSSETTI: Towards a more personalized treatment of stroke

The boom in interventional radiology procedures has enabled great strides in ischemic stroke management. But while a myriad of techniques are available, the challenge remains in choosing the most…

Photo

News • Research on RAD51 biomarker

Next-generation sequencing for personalizing prostate cancer treatment

Certain gene alterations can serve as a prognostic and predictive biomarker for prostate cancer. Now, researchers confirm the feasibility of using NGS on this marker for precise patient…

Photo

News • Multifunctional wearable

Smart patch combines health monitoring and drug delivery

Researchers developed a smart patch capable of real-time biometric signal monitoring and drug delivery. Potential applications include glucose management, pain relief, and chronic disease treatment.

Photo

News • Early-stage disease stratification

Predicting lung cancer outcomes with tumour DNA in the blood

A new personalised oncology platform has been tested to detect circulating tumour DNA (ctDNA) in patients with lung adenocarcinoma before surgery, to predict their risk of cancer relapse.

Photo

News • Tackling bacterial infections

Personalised phage therapy as alternative to antibiotics

The current rise in antibiotic resistance is once again sparking interest in phage therapy. Now, scientists developed a new tool that recommends the best possible phage cocktail for a given patient.

Photo

Article • Progress, limitations, and opportunities

Precision oncology: incredible potential, but not a miracle cure

Unanswered questions are hampering clinicians in their efforts to get the best out of a precision medicine approach for their patients. Speaking at the Genomics and Precision Medicine Expo in London at the end of May, cancer educator Dr Elaine Vickers said the benefits of being matched to an investigational drug remain questionable for most people with advanced cancer.

222 show more articles
Subscribe to Newsletter